Month: November 2023

FAB, Halo Investing sign MoU to advance Structured Notes business

ABU DHABI, United Arab Emirates, Nov. 28, 2023 (GLOBE NEWSWIRE) — First Abu Dhabi Bank (FAB), the largest bank in the UAE, and Halo Investing, a global leader in Protective Investments™, headquartered in Chicago with offices in Abu Dhabi and Zurich, have signed a Memorandum of Understanding (MoU) to enhance FAB’s structured notes business on […]

Read More

Nyxoah Strengthens its Executive Leadership Team

Francis Kim appointed as Chief Regulatory and Quality Officer Mont-Saint-Guibert, Belgium – November 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Francis […]

Read More

4.8 Magnitude Earthquake Hits Central Peru

Lima, An earthquake measuring 4.8 magnitude on the Richter scale hit Wednesday Huaral Province in central Peru.The US Geological Survey said that the quake occurred nine kilometers southeast of Pacaraos District in the Province, at a depth of 94.6 kil…

Read More

KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global Experts and Specialists

– Honorary Accreditation of the Nursing Residency Program announced KFSH&RC Jeddah Hosts The 10th International Nursing Conference Gathering Renowned Global Experts and Specialists _02 RIYADH, Saudi Arabia, Nov. 27, 2023 (GLOBE NEWSWIRE) — The 10th International Nursing Conference commenced this morning in Jeddah, themed ‘Nurses: As Catalysts, Navigators & Innovators in Healthcare’. Organized by the […]

Read More

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – BCLI

NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the securities […]

Read More